The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study "diaVAX".

Ilhan Satman, Sema Akalin, Bekir Cakir, Serdar Altinel, diaVAX Study Group
Author Information
  1. Ilhan Satman: Istanbul University; Istanbul Faculty of Medicine; Istanbul, Turkey.
  2. Sema Akalin: Marmara University; Medical Foundation; Istanbul, Turkey.
  3. Bekir Cakir: Yildirim Bayezit University; Ataturk Training and Research Hospital; Ankara, Turkey.
  4. Serdar Altinel: Sanofi-Pasteur; Istanbul, Turkey.

Abstract

We aimed to examine the effect of increased physician awareness on the rate and determinants of influenza and pneumococcal vaccinations in diabetic patients. Diabetic patients (n = 5682, mean [SD] age: 57.3 [11.6] years, 57% female) were enrolled by 44 physicians between Sept 2010 and Jan 2011. The physicians were initially questioned regarding vaccination practices, and then, they attended a training program. During the last five years, the physicians recommended influenza and pneumococcal vaccinations to 87.9% and 83.4% of the patients, respectively; however; only 27% of the patients received the influenza and 9.8% received the pneumococcal vaccines. One year after the training, the vaccination rates increased to 63.3% and 40.7%, respectively. The logistic regression models revealed that variables which increased the likelihood of having been vaccinated against influenza were: longer duration of diabetes, presence of hyperlipidemia and more use of concomitant medications whereas more use of anti-hyperglycemic medications was associated with increased odds of vaccination. On the other hand, older age, longer duration of diabetes and presence of a cardiovascular disease were variables which decreased the likelihood of having been vaccinated against pneumococcal disease during the past five years. However, during the study period, variables which decreased the odds of having been vaccinated included: older age and anti-hyperglycemic medications for influenza, and presence of hyperlipidemia and a family history of hypertension for pneumococcal disease. While variables which increased the likelihood of vaccination in the same period were: increased number of co-morbidities for influenza, and family history of diabetes for pneumococcal disease. We conclude that increased awareness of physicians may help improve vaccination rates against influenza and pneumococcal disease. However, diabetic patients with more severe health conditions are less likely to having been vaccinated. More structural/systematic vaccination programs are needed to increase the vaccination rates in patients with diabetes.

Keywords

References

  1. Diabetes Res Clin Pract. 2012 Oct;98(1):75-82 [PMID: 22652276]
  2. CMAJ. 2012 Oct 16;184(15):1673-81 [PMID: 22966054]
  3. MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6 [PMID: 20814406]
  4. MMWR Recomm Rep. 1997 Jan 3;46(RR-1):1-79 [PMID: 9036304]
  5. Infect Control Hosp Epidemiol. 2004 Nov;25(11):933-40 [PMID: 15566027]
  6. Hum Vaccin Immunother. 2013 Jun;9(6):1326-32 [PMID: 23403458]
  7. MMWR Suppl. 2011 Jan 14;60(1):38-41 [PMID: 21430618]
  8. Wkly Epidemiol Rec. 2005 Aug 19;80(33):279-87 [PMID: 16171031]
  9. Hum Vaccin. 2011 Apr;7(4):441-50 [PMID: 21441776]
  10. JAMA. 1993 Oct 20;270(15):1826-31 [PMID: 8411526]
  11. Am J Public Health. 1989 Oct;79(10):1422-4 [PMID: 2782519]
  12. BMC Public Health. 2006 Sep 18;6:231 [PMID: 16981982]
  13. Vaccine. 2008 Mar 10;26(11):1432-7 [PMID: 18272261]
  14. BMC Public Health. 2010 Oct 13;10:603 [PMID: 20942933]
  15. Diabetes Care. 2004 May;27(5):1143-7 [PMID: 15111535]
  16. Diabetes Care. 2013 Jan;36 Suppl 1:S11-66 [PMID: 23264422]
  17. BMC Geriatr. 2010 Jun 30;10:44 [PMID: 20591180]
  18. J Infect. 2009 Jun;58(6):446-58 [PMID: 19446340]
  19. Vaccine. 2011 Apr 5;29(16):3031-7 [PMID: 21335033]
  20. Diabetes Res Clin Pract. 2008 Mar;79(3):510-7 [PMID: 18035444]
  21. BMC Infect Dis. 2009 Mar 25;9:37 [PMID: 19321001]
  22. MMWR Suppl. 2013 Feb 1;62(1):9-19 [PMID: 23364303]
  23. Public Health Rep. 2012 Jan-Feb;127 Suppl 1:1-42 [PMID: 22210957]
  24. Eur J Public Health. 2012 Aug;22(4):562-8 [PMID: 21750011]
  25. Br J Gen Pract. 2002 Sep;52(482):735-40 [PMID: 12236277]

MeSH Term

Adult
Age Factors
Aged
Diabetes Complications
Epidemiologic Studies
Female
Humans
Influenza Vaccines
Influenza, Human
Male
Middle Aged
Physicians
Pneumococcal Infections
Pneumococcal Vaccines
Professional Competence
Turkey
Vaccination

Chemicals

Influenza Vaccines
Pneumococcal Vaccines

Word Cloud

Created with Highcharts 10.0.0influenzapneumococcalvaccinationincreasedpatientsdiabetesdiseasephysiciansratesvariablesvaccinatedawarenessyearslikelihoodpresencemedicationseffectvaccinationsdiabetictrainingfiverespectivelyreceivedwere:longerdurationhyperlipidemiauseanti-hyperglycemicoddsolderagedecreasedHoweverperiodfamilyhistoryprogramsvaccineaimedexaminephysicianratedeterminantsDiabeticn=5682mean[SD]age:573[116]57%femaleenrolled44Sept2010Jan2011initiallyquestionedregardingpracticesattendedprogramlastrecommended879%834%however27%98%vaccinesOneyear633%407%logisticregressionmodelsrevealedconcomitantwhereasassociatedhandcardiovascularpaststudyincluded:hypertensionnumberco-morbiditiesconcludemayhelpimproveseverehealthconditionslesslikelystructural/systematicneededincreasephysicians'correlatesTurkey:epidemiologicalStudy"diaVAX"adultmellitusimmunization

Similar Articles

Cited By